ArticleFrontiers in oncology2022

NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma.

Wenjun Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.